SHERIDAN, WYOMING – May 1, 2025 – Straumann Group has delivered a strong start to 2025, reporting CHF 680.7 million in first-quarter sales, with an impressive 11.0% organic growth. Despite a backdrop of ongoing macroeconomic headwinds, the company’s performance was driven by robust regional expansion in EMEA and APAC, strategic innovation in digital dentistry, and continued success in both premium and challenger implant segments.
Double-Digit Growth Across Key Markets Strengthens Global Footprint
Straumann’s largest region, Europe, Middle East & Africa (EMEA), led the Group’s performance with CHF 280.0 million in revenue and 10.0% organic growth. Germany continued to anchor regional momentum, while Italy, Spain, and Belgium posted strong gains. The success was fueled by the launch of the iEXCEL implant system and expanded market presence of challenger brands Neodent and Anthogyr. Orthodontics, led by ClearCorrect, also delivered double-digit growth.
Asia Pacific (APAC) recorded the highest growth trajectory, with sales reaching CHF 162.2 million and 23.0% organic growth. The Chinese market, bolstered by the government’s Volume-Based Procurement Initiative, remained the top contributor. Emerging economies such as Thailand, India, and Malaysia also showed significant acceleration, while digital solutions like the SIRIOS intraoral scanner enhanced overall performance.
In contrast, North America showed modest progress with 1.8% organic growth and CHF 185.1 million in revenue. The subdued U.S. implantology market was partially offset by the positive reception of the iEXCEL system and growth in digital prosthetics via the UN!Q service. Latin America posted a strong 18.8% organic growth, led by Brazil and Mexico, with Neodent again playing a central role.
Strategic Launches and Partnerships Accelerate Digital Dentistry Transformation
At March’s International Dental Show (IDS) in Cologne, Straumann unveiled multiple innovations aimed at reshaping digital workflows in dentistry. The global launch of the iEXCEL implant system was a centerpiece, offering a simplified, high-performance solution with four implant designs unified under one system.
Key new releases also included:
- Falcon: A dynamic navigation system enabling real-time guided surgery.
- UN!Q: A cloud-based prosthetics service facilitating on-demand, lab-to-chairside production of restorations.
The innovations support Straumann’s AXS platform, an integrated cloud-based digital ecosystem linking diagnostics, surgical planning, and prosthetics delivery. With intraoral scanning (SIRIOS) and AI-powered planning (coDiagnostiX), AXS reduces workflow complexity and improves clinical outcomes.
Strategic partnerships also underscored Straumann’s commitment to digital innovation:
- SprintRay Collaboration: The new Signature Midas 3D printer, fully integrated with AXS and SIRIOS, enables chairside production of crowns and inlays in under 10 minutes.
- Carestream Dental Partnership: Integrates CBCT data into AXS, streamlining diagnostics and surgical planning.
CEO Endorses Long-Term Vision Amidst Global Challenges
"I am very pleased with the results of this quarter, which we achieved together as a team, and with the positive response we received at IDS," said Guillaume Daniellot, Chief Executive Officer. "The numerous innovations we presented, our strategic partnerships and our continuous investment in growth underscore our ability to actively shape the future of dentistry – and form a strong basis for sustainable business success."
Annual General Meeting Approves Strategic Initiatives and Dividend Increase
Shareholders at the April 10 Annual General Meeting approved all board proposals, including a raised dividend of CHF 0.95 per share, distributed on April 16.
2025 Outlook Remains Positive Despite Market Uncertainties
Straumann reaffirmed its 2025 outlook, targeting:
- High single-digit organic sales growth
- Core EBIT margin improvement of 30–60 basis points, at constant exchange rates
The Group attributes its resilience to its diversified product offering, strong brand portfolio, expanding production capabilities, and commitment to training healthcare professionals worldwide.
As digital transformation and clinical demand continue to shape the dental industry, Straumann remains focused on driving innovation and delivering value across all global markets. Learn more at www.straumann.com.